B7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future direction.
Gettinger, Scott
B7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future direction. [electronic resource] - Cancer journal (Sudbury, Mass.) - 281-9 p. digital
Publication Type: Journal Article; Review
1540-336X
10.1097/PPO.0000000000000063 doi
Antineoplastic Agents--pharmacology
B7-H1 Antigen--antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials as Topic
Humans
Immunotherapy--methods
Lung Neoplasms--diet therapy
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Randomized Controlled Trials as Topic
B7-H1/PD-1 blockade therapy in non-small cell lung cancer: current status and future direction. [electronic resource] - Cancer journal (Sudbury, Mass.) - 281-9 p. digital
Publication Type: Journal Article; Review
1540-336X
10.1097/PPO.0000000000000063 doi
Antineoplastic Agents--pharmacology
B7-H1 Antigen--antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung--drug therapy
Clinical Trials as Topic
Humans
Immunotherapy--methods
Lung Neoplasms--diet therapy
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Randomized Controlled Trials as Topic